CNBC
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
EconomyDaily Composite
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
C
Source
CNBC
Read full article at CNBC
Opens original article in a new tab
Advertisement
